Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Aprimeo Diagnostics Nordic AS
AS
Active
Org 925223166
Ole Deviks vei 16A, 0666
Oslo
Activities of agents involved in the wholesale of other particular products
·
NACE 4618
Est. 2020 · 6 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Activities of agents involved in the wholesale of other particular products
/
Aprimeo Diagnostics Nordic AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
66M
50M
33M
17M
0M
2020: 0M
0M
2020
2021: 53M
53M
2021
2022: 19M (-64% vs 2021)
19M
-64%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
EBITDA
NOK millions
6M
3M
1M
-1M
-4M
2020: -1M
-1M
2020
2021: 2M (+300% vs 2020)
2M
+300%
2021
2022: 4M (+100% vs 2021)
4M
+100%
2022
2023: -2M (-150% vs 2022)
-2M
-150%
2023
Income statement
NOK thousands
Item
2023
2022
2021
2020
Revenue
486
19 062
52 943
0
Staff expenses
−0
−0
−0
−0
EBITDA
−2 075
3 823
1 791
−1 111
Depreciation & amort.
−36
−36
−36
−0
EBIT
−2 111
3 787
1 755
−1 111
Net financials
678
373
22
0
Profit before tax
−1 433
4 160
1 778
−1 111
Tax
−313
915
403
−244
Net profit
−1 120
3 245
1 375
−866
Balance sheet
NOK thousands
Item
2023
2022
2021
2020
Total assets
6 403
13 623
24 593
8 197
Equity
4 618
10 383
7 139
5 764
Long-term debt
0
0
0
0
Short-term debt
1 785
3 239
17 455
2 433
Total debt
1 785
3 239
17 455
2 433
Financial ratios
5-year trend
EBITDA margin
−427,1 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2023
Equity ratio
72,1 %
This company
38,2 %
Market median
This company
Market median
89% above market
2020
2023
Return on equity
−24,3 %
This company
18,4 %
Market median
This company
Market median
232% below market
2020
2023
Net profit margin
−230,6 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2023
Asset turnover
0,08×
This company
1,12×
Market median
This company
Market median
93% below market
2020
2023
Debt / equity
0,39×
This company
0,62×
Market median
This company
Market median
37% below market
2020
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Aprimeo Diagnostics Nordic AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
